Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.65 HKD | +2.28% | +14.39% | +17.94% |
04-25 | Everest Medicines' Loss Widens in 2023 | MT |
03-28 | Everest Medicines Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 432
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 15 | 100.0 % | 139 | 100.0 % | +835.46% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore
100.0
%
| 15 | 100.0 % | 139 | 100.0 % | +835.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Jennifer Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-04-14 |
Xu Xin Liu
IRC | Investor Relations Contact | 40 | 21-09-30 |
Yang Shi
PRN | Corporate Officer/Principal | 48 | 19-01-31 |
Zhengying Zhu
PRN | Corporate Officer/Principal | 51 | 17-10-31 |
Xu Zhu
PRN | Corporate Officer/Principal | 54 | 17-09-30 |
Yee Wa Lau
SEC | Corporate Secretary | 52 | - |
Jason M. Brown
PRN | Corporate Officer/Principal | 52 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | 02-08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Ki Chul Cho
BRD | Director/Board Member | 46 | 01-11 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Shi Dong Jiang
BRD | Director/Board Member | 57 | 20-08-31 |
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Hoi Yam Chui
BRD | Director/Board Member | 57 | 23-01-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 328,532,049 | 193,532,752 ( 58.91 %) | 4,348,701 ( 1.324 %) | 58.91 % |
Company contact information
Everest Medicines Ltd.
CITIC Pacific Plaza 1168 West Nanjing Road
200041, Shanghai
+
http://www.everestmedicines.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.94% | 1.01B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 1952 Stock
- Company Everest Medicines Limited